20.01.2016 • NewsDede WillamsBayerChemChina

Former Bayer Manager Hired by ChemChina

As Asia’s burgeoning chemical giant ChemChina sharpens its focus on European takeover targets – it recently bought plastics machinery manufacturer Krauss Maffei and made a bid for Swiss agrochemical producer Syngenta – the company has come into focus again, hiring a former Bayer manager, Michael König, to run its China National Bluestar Corp subsidiary.

Bluestar, which holds ChemChina’s specialty chemicals activities, is no stranger to Bayer, having worked with the German group on chlorine technology. König, who from 2013 until resigning the position at the end of last year, was responsible for Human Resources on the Bayer managing board, is no stranger to China either.

Relocating to the People’s Republic for in 2000, the German exceutive spent several years building the chemical producer’s business in Asia, mainly for the engineering plastics activities belonging to sub-group Bayer MaterialScience, now spun off and trading as Covestro, A Mandarin speaker, König is credited with having extensive experience in dealing with Chinese authorities.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.